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Summary 
Polymyositis mediated by 3'/~ T cells is a unique disease in which autoaggressive T lymphocytes 
surround, invade, and destroy muscle fibers. Histochemically, the vast majority of muscle-infiltrating 
T cells in a patient with polymyositis were reactive with a pan-7//~ T cell receptor (TCR)-specific 
monodonal  antibody  (TCR-~I+),  but  unlike  >90%  of peripheral  blood 7//~  T  cells,  these 
lymphocytes did not  react  with  V~I-  or V79-specific antibodies  (A13-  and Ti3,A-,  respec- 
tively). Differential reactivity with two different V~2-specific monoclonal antibodies (BB3-/ 
TiV-~2 +) indicated that  the infiltrating  T  cells express a V62-containing  TCR with unusual 
additional structural  features. Using conventional and anchored polymerase chain reaction for 
the  analysis  of TCR transcripts,  we found a striking  predominance  of one unusual  V/~2-J~3 
recombination and one V73-J71 recombination.  Both the unusual phenotype (TCR-~I +/A13-/ 
TiTA-/BB3-/TiV-/~2 +) and the dominance of distinct  TCR transcripts  are compatible with 
the assumption that  one T  cell done, which expresses a V3,3-J71-C3,1/V~2-J/~3-C~  disulfide- 
linked TCR, dominates among the infiltrating T cells of the polymyositis muscle specimen analyzed. 
though 3'//~ T  cells are suspected to be involved in au- 
toimmunity,  there is little direct evidence to support 
this hypothesis in human autoimmune disease. One notable 
exception is a recently described inflammatory muscle dis- 
ease that represents a variant of polymyositis (1). In this dis- 
ease autoaggressive 7/~ T  cells can be demonstrated to sur- 
round,  invade,  and destroy muscle fibers (1).  Our  analysis 
of TCR transcripts of the myocytotoxic T cells provides the 
first complete structural description of a TCR used by au- 
toaggressive human  3'/~  T  cells. 
Materials  and Methods 
Clinical Material.  A biopsy specimen of the left triceps muscle 
of a patient  previously described (1) was taken before treatment 
and was divided for immunocytochemical  studies and for RNA 
extraction. 
Immunohistology.  4-#m cryostat sections of muscle were used 
for single and paired immunofluorescence studies. The following 
antibodies were used: anti-CD3 (5 ~g/ml; Dako Corp.,  Carpen- 
teria,  CA); anti-TCR-61 (5 ~g/ml; T Cell Sciences, Cambridge, 
MA);  TiTA  (5 /zg/ml;  T.  Hercend,  Institute  Gustave Roussy, 
Villejuif, France); TIV-/~2 (2/zg/ml;  T. Hercend);  A13 and BB3 
(6  ~g/ml;  L.  Moretta,  Istituto  Nazionale  Per La  Ricerca  Sul 
Cancro, Genova, Italy). All antibodies were mouse mAbs except 
anti-CD3,  which was an affinity-purified rabbit polyclonal anti- 
body. The primary mouse mAbs were detected using a biotin-labeled 
second antibody followed  by treatment either with rhodamine-avidin 
or with HTC-avidin.  The rabbit anti-CD3  primary antibody was 
detected using rhodamine-labeled goat anti-rabbit IgG. Isotype- 
matched IgG at identical concentrations  was substituted  for pri- 
mary antibodies for negative controls. Smears of PBMC and thymo- 
cytes were used as positive controls for antibodies specific  for subsets 
of 7/8 T cells. Tissue samples used as controls included sections 
from patients with different inflammatory  myopathies and from 
normal  control subjects with no evidence of muscle disease. 
Analysis of TCR Transcripts.  Total  RNA was prepared from a 
sample  (25  mg)  of the  muscle  biopsy specimen  by  the  acid 
guanidinium  thyocyanate phenol-chloroform  method (2) and its 
integrity verified by running a portion of the material on an agarose 
gel,  First-strand  cDNA was prepared from total  RNA using  a 
poly(dT) primer and AMY reverse transcriptase (Boehringer, Mann- 
heim, Germany) (3). PCR was carried out as described previously 
(3, 4) with 0.5 ~M of oligonucleotide primers and 1 U ofTaq poly- 
merase (Bethesda Research Laboratories, Gaithersburg, MD) using 
incubation  times of 30 s at 93~  1 min at 50~  and 1 min at 
720C in a reaction volume of 100 ~1. DNA bands of the expected 
size were isolated from 1% agarose gels and blunt-end cloned into 
the Sinai site of Bluescript KS (Stratagene, La Jolla, CA) (3). Double- 
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kit (U.S. Biochemical Co., Cleveland, OH). 
PCR amplification  of ~ chain eDNA was accomplished  by use 
of a C~ antisense primer (GACAAGCGACATTTGTTCCA) in 
combination with either a V~2 sense  primer (CAAAGAACCTGG- 
CTGTAC) or a set of V~ sense primers (V$I: TACTCTGGATCA- 
AGTGTGGC; V~2: GCAGGAGTCATGTCAGCCA~  V~3: GGC- 
ACGCTGTGTGACAAAGT). In  one  experiment  the  relative 
abundance of V~2-J~l and V~2-J~3 rearrangements in eDNA de- 
rived from the muscle biopsy, and from Ficoll-purified  PBMC of 
a healthy donor, were compared. Here amplifications were done 
using a V~2 sense primer (GCAGGAGTCATGTCAGCCAT)  ei- 
ther in combination  with aJ~l (GGTTCCACAGTCACACGGGT) 
or with aJ~3 (GGCTCCACGAAGAGTTTGAT)  antisense  primer. 
For the analysis  of the  junctional regions of 3' chain transcripts, 
eDNA derived from the muscle  biopsy was amplified  using single- 
sided PCR carried out by a modification (4) of  a published method 
(5). eDNA was size fractionated  by Bio-Gel  A-5m (Bio-Rad  Labora- 
tories, Richmond, CA) column chromatography and an oligo(dG)- 
tail was added to the 3' end of cDNAs of appropriate size using 
terminal deoxynucleotide transferase (Bethesda Research Labora- 
tories) (4). Two successive amplifications of the oligo(dG)-tailed 
eDNA were accomplished with an oligo(dC) primer (dC16) in 
combination  with one of  two different  C7 (exon 1) antisense  primers 
(GGTATGTTCCAGCCTTCTGG  or the nested C7 primer AAG- 
GAAGAAAAATAGTGGGC).  Analysis of 7 chain transcripts by 
conventional PCR was done with C'y (exon 1) antisense primers 
(AAGGAAGAAAAATAGTGGGC)  in combination with a set of 
Vy sense primers (Vy subgroup I: TGCTTCTAGCTTTCCTG; 
V79:  ATCAACGCTGGCAGTCC; V710: TCCTCCTGC~CT- 
CCTGA; V~11: TTCTTCTCCCTCTGGGT)  or with Cy (exon 
3) antisense  primers (TGAGGAGCAGGAGGAGGTAC)  in combi- 
nation with a V~ subgroup I sense primer (TGCAGCCAGTCA- 
GAAATCTT). Since  the different  V3' gene segments of subgroup I 
are highly homologous (6), it was possible to design universal 
primers for the amplification  of rearrangements with all members 
of this subgroup. 
Results and Discussion 
For the analysis of the structure and heterogeneity of TCR 
transcripts from muscle-infiltrating "),//~ T  cells, RNA was 
Figure 2.  V62-J~1  and V/~2-J/J3 
TCR  gene rearrangements ex- 
pressed in muscle-infiltrating  lym- 
phocytes  (MIL)  and PBL. Agarose 
gel  analysis of ethidium bro- 
mide-stained  PCK amplification 
products, eDNA obtained from 
the muscle  biopsy  or from  Ficoll- 
purified mononuclear  cells from 
a healthy donor was amplified 
with a V~2 sense  primer in com- 
bination  with either  aJ$1 or aJ$3 
antisense primer. 
isolated from a polymyositis  biopsy specimen that had previ- 
ously been characterized by immunohistology  (1). RNA was 
transcribed  into  eDNA,  and  TCR-specific  cDNA  was 
amplified either by conventional or by anchored PCR. PCR 
products of expected size were cloned and the sequences of 
independently isolated clones analyzed. A set of sense primers 
for the most commonly used V~ gene segments, V~I, V~2, 
and V~3 (7),  was used in combination with a C6 antisense 
primer for the amplification of eDNA derived from TCR 
chain transcripts. Only V~2 PCR products were obtained 
and only one unique rearrangement was found when ran- 
domly chosen clones were analyzed (Fig. 1 A). One D~ gene 
segment and nongermline-encoded nucleotides at the V-D 
and the D-J junctions contributed to the junctional region 
of this dominant transcript. While both ends of the D~ gene 
segment were shortened, the entire coding sequences of the 
V~ and the J~ gene segments were conserved in this rear- 
rangement. To rule out the possibility that the dominance 
of this sequence was the result of an accidental  preferential 
amplification of  one particular cDNA, we performed a second 





V~,  p/N  D53  P/N  J~53  Frequency 
TGT GCC TGT GAC ACG  GT  CTGGGGGA  CCTCAAAGAG  C TCC TGG GAC  9/10 
TGT GCC TGT GAC ACC  GT  CTGGGGGA  CCTCTAAGAG  C TCC TGG GAC  1/10 
TGT GCC TGT GAC ACC  GT  CTGGGGGA  CCTCAAAGAG  C TCC TGG GAC  4/6 
TGT GCC TGT GAC ACC  GT  TTGGGGGA  CCTCAAAGAG  C TCC TGG GAC  1/6 
TGT GCC TGT GAC ACC  GT  CAGGGGGA  CCTCAAAGAG  C TCC TGG GAC  1/6 
TGT GCC TGT GAC ACC caccctg 
cactgtg ACTGGGGGATACG  cacagtg 
taatgtg C TCC TGG GAC 
Figure 1.  Junctional  regions  of/~ 
chain  cDNA sequences from 
muscle-infiltrating  3"/~  T cells. The 
3' and the 5' ends of the V, D, and 
J  regions were determined from 
genomic clones  (8,  9).  PCR 
amplification  of the ~ chain  eDNA 
was accomplished  by use of  a CA an- 
tisense  primer in combination  with 
a set of sense  primers  for V81, V62, 
and V63 (A), or a second  different 
V#2 sense primer (B). 
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A 
TGT GCC ACC TGG GAC  GG'I-r  AT TAT TAT AAG AAA  14/14 
B 
TGT GCC ACC TGG GAC  GGTI"  AT TAT TAT AAG AAA  5/5 
C 
TGT GCC ACC TGG GAC  GGTT  AT TAT TAT AAG AAA  10/13 
TGT GCC ACC TGG GAC  GGTT  AT TAT TAT AAG AAG  1/13 
TGT GCC ACC TGG GAC  A  CAGAAG  AT TAT hAG AAA  2/13 
gerrnllne TGT GCC ACC TGG GAC AGGcacagtg  cactgtgG  AAT TAT TAT AAG AAA 
Figure 3.  Junctional regions of"/chain cDNA se- 
quences from muscle-infiltrating 7'//$ T cells. The 3' 
and the 5' ends of the V and J regions, respectively, 
were determined from genomic clones (6,  14). Five 
J'y segments have  been identified, with J',/1 being iden- 
tical in amino acid sequence to J3~2. J')'l is located up- 
stream of C~/1, whereas J3~2 is located between C~/1 
and C'),2 (14, 15). cDNA was amplified  by single-sided 
PCR (.4), by conventional PCR using a C3' (exon 1) 
antisense primers in combination  with a set of sense 
primers for the different V3' families (B), or by con- 
ventional PCR using a C~/(exon 3) antisense primers 
in combination with a V3' subgroup I sense  primer (C). 
primer. All clones derived from this second amplification 
product were identical to the rearrangement observed in the 
first experiment (Fig. 1 B). A few of the analyzed  junctional 
sequences differed from the others by a single nucleotide ex- 
change. Since the fidelity of the Thermus  aquaticus (Taq) DNA 
polymerase in  DNA  amplification is  relatively  low,  such 
polymerase-induced point  mutations  tend  to  accumulate 
during PCR amplification (10). 
A high proportion of 3'//i T cells in peripheral blood ex- 
press a limited receptor repertoire: V~2-J~I-C/~ usually pairs 
with V3'9-J3'P-C3'l  (11, 12). V/f2-J/~3 rearrangements such 
as the one observed here have previously been described in 
3'/~ T  cell dones (13), but are rare in peripheral blood T 
cells. To further verify the dominance of V/~2-J~3 transcripts 
in the muscle biopsy, PCR was performed with a V/i2 sense 
primer in combination with either a J~3 or a J~l antisense 
primer. Whereas only a V~2-J/~3-PCR band was observed 
when cDNA from the muscle biopsy was used as a template, 
a V/~2-J~l-band was dominant in reactions with cDNA de- 
rived from PBL (Fig. 2). This demonstrates that the majority 
of 3'//~ T  cells in the biopsy represent a unique subpopula- 
tion rather than a polyclonal infiltrate of peripheral T cells. 
This conclusion is further supported by the observation that 
;>90%  of the 3"//~ T  cells present in the blood at the time 
of biopsy had a different phenotype (BB3 +,  Ti3'A +)  than 
the infiltrating 3'/~ T  cells (BB3-,  Ti3'A-)  (1). 
For the analysis of TCR 3' chain transcripts a modification 
of the single-sided PCR amplification method (4, 5) was used 
that requires  sequence information only from the 3' end of 
the target receptor cDNA (constant gene segment) and there- 
fore allows V segment sequence-independent amplification. 
PCR products in the predicted size range were cloned and 
the  sequences  of a  set  of randomly chosen isolates  were 
determined. All 14 sequences analyzed were identical, rep- 
resenting a V3'3-J3'l  recombination with addition of four 
nongermline-encoded  nucleotides and shortening of  both the 
V and the J coding region by imprecise  joining (Fig. 3 A). 
The same sequence was obtained when an independent second 
amplification was performed by conventional PCR with a 
set of sense primers for all eight functional human V3' gene 
segments (Fig.  3 B). 
Of the 14 V3' gene segments that have been identified in 
the human genome, six are considered to be pseudogenes. 
The functional genes fall into four distinct subgroups (15). 
Whereas five functional genes (V3'2, V3'4, V3'5,  and V3'8, 
in addition to the V3"3 gene segment found in the transcripts 
analyzed here) belong to subgroup I, subgroups II, III, and 
IV each consist of a single gene (V3'9, V3'10, V3"11, respec- 
tively).  The degree of variation of the 3' chains is increased 
by the existence of polymorphic 3' constant region gene seg- 
ments (C3"). The C3'1 gene segment consists of three exons 
(exl, ex2, ex3), whereas C3"2 contains in some cases two and 
in others three copies of exon 2 (15, 16). Exons 1 and 3 of 
both gene segments are virtually identical.  The C3"1 gene 
products possess a cysteine residue in the second exon that 
is responsible for disulfide bond formation with the 6 chain, 
while the corresponding exon 2 of C3'2 lacks the cysteine. 
It is not known whether these structural differences between 
Figure 4.  Localization of CD3 antigen with red rhodamine fluorescence (A) and of the TIV-$2 antigen with green FITC fluorescence. (,4) CD3 + 
T  cells focally surround and invade a muscle fiber. (B) Demonstration that most of these cells are TiV-62  + cells. (C) Double exposure of A  and B, 
revealing CD3 + TiV-62  + cells in yellow. A  and/3,  x410;  C,  ￿ 
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TCR.  It is known, however, that the V3' and the Jy seg- 
ments associated with C3d and C3'2 differ at least in periph- 
eral blood 3'//~ T cells, where C'y1 is preferentially rearranged 
with V3'9/J'yP and C'y2 with Vqr2/J3d (17). To analyze the 
C~/gene usage in the muscle-invading T cells, we performed 
PCR with a V3~ subgroup  I sense primer in combination 
with a C3~ exon 3 antisense primer, and sequenced the brack- 
eted DNA. This analysis revealed an association of the domi- 
nant V3r3-Jyl rearrangement with C3d. In addition, we ob- 
served one additional unique V3'3 rearrangement (Fig. 3 C) 
associated  with a C3'2 gene segment that contained three copies 
of exon 2. The fact that the very same sequences were found 
in the products of several independent amplifications using 
different amplification techniques and primers rules out the 
possibility that the dominance of the V~2-J/~3 and Vy3-J3d 
rearrangements are merely PCR artifacts. Furthermore, a pre- 
liminary PCR analysis of TCR transcripts from another small 
portion of the biopsy had also yielded the dominant V~2-J/~3 
and V'y3-J3d rearrangements.  Here V~2-J~l  and V3'9-J3'P 
rearrangements that are commonly found in peripheral 3//~ 
T  cells and  thus presumably  derived from contaminating 
PBMC were obtained  in addition. 
Taken together,  the above results suggest that one T cell 
clone expressing a V/~2-J/B-C/VV3~3-Jyl-C'rl disulfide-linked 
TCR dominates the population of infiltrating T cells of the 
analyzed muscle specimen. The phenotype of the vast majority 
of 3~/~ T cells in this specimen was previously established 
as  CD2 +,  CD3 +,  CD4-,  CD8-,  TCR-~I +,  Ti3/A-, 
A13-, BB3-  (1). While TCR-~I stains all 3///~ T cells, the 
mAbs TiyA and A13 are specific for subsets V'y9 or V~I, 
respectively. While the observed TCR:~I +, TiyA-, A13- 
staining pattern was expected for a V3/3/V~2-expressing T 
cell population,  the BB3- phenotype seems to be incompat- 
ible with the genetic data, since BB3 is considered specific 
for V/~2 (18). One possible explanation for the discrepancy 
was that the rare V~2-J53 rearrangement and/or combination 
with V3'3 eliminates the epitope recognized by mAb BB3. 
To address this problem, we used another V~2-specific  mAb, 
TiV-/~2 (19), for additional  immunohistochemical studies. 
All the T cells surrounding and invading muscle fibers reacted 
with TiV-~2 (Fig. 4), indicating that these cells express V52, 
although in a form that is not recognized by antibody BB3. 
Hence, both sequence analyses and antibody reactivities are 
consistent with the assumption that the autoaggressive lym- 
phocytes express a Vy3-Jyl-C~/1/V~2-Ji~3-C~ TCR that is 
unusual both with respect to its V~-J/~ recombination and 
its  specific V3'/V/~ combination. 
In conclusion, our results provide the first complete descrip- 
tion of a human y/~ TCR expressed by autoaggressive T 
cells. A striking predominance of one clone of T cells was 
observed in the inflammatory muscle infiltrate. This clone 
uses an unusual combination of TCR V and J segments and 
is associated with a TCR phenotype that has not previously 
been described among the major populations  of human "y/~ 
T cells. It should be noted that Mycobacteria- and heat shock 
protein-responsive  y/~ T cells, which have been postulated 
to participate in autoimmune processes (20), express domi- 
nantly V3,9-JTP/V~2-J~I TCR variable regions (21-23). We 
anticipate  that the molecular characterization  of the V3,3- 
J'y1-C3'l/V/~2-J/~3-C~ TCR associated  with the myocytotoxic 
T cells, which share only the V/~2 segment with the known 
heat shock protein-reactive T cells, may eventually help to 
identify the unknown autoantigen in this disease. 
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